Titan Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 25,783 | 2.82% |
Individual Insiders | 214,178 | 23.4% |
General Public | 674,273 | 73.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
190,105 | US$729.2k | 0% | no data | |||
11,066 | US$42.4k | 0% | no data | |||
5,000 | US$19.2k | 0% | no data | |||
4,881 | US$18.7k | 0.54% | no data | |||
4,773 | US$18.3k | 477,000% | no data | |||
4,103 | US$15.7k | 0% | no data | |||
3,321 | US$12.7k | 0% | no data | |||
3,313 | US$12.7k | 0% | no data | |||
3,313 | US$12.7k | 0% | no data | |||
3,313 | US$12.7k | 0% | no data | |||
3,313 | US$12.7k | 0% | no data | |||
2,500 | US$9.6k | 0% | no data | |||
743 | US$2.8k | 3.63% | no data | |||
165 | US$633.0 | 0% | no data | |||
17 | US$65.2 | 0% | no data | |||
12 | US$45.9 | 0% | no data | |||
7 | US$27.0 | 0% | no data | |||
4 | US$15.4 | 33.3% | no data | |||
3 | US$11.6 | 0% | no data | |||
2 | US$7.7 | 0% | no data | |||
1 | US$3.9 | 0% | no data | |||
1 | US$3.9 | 0% | no data | |||
1 | US$3.9 | 0% | no data | |||
1 | US$3.9 | 0% | no data | |||
1 | US$3.9 | 0% | no data |